![Sung-Sun Cho](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sung-Sun Cho
Chief Executive Officer at YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.
Profile
Sung-Sun Cho is currently the Chief Executive Officer and Director at Yuanta 4 SPECIAL PURPOSE ACQUISITION Co., Ltd.
Prior to this, Mr. Cho was the Chief Executive Officer at ProCell Therapeutics, Inc.
Sung-Sun Cho active positions
Companies | Position | Start |
---|---|---|
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Chief Executive Officer | - |
Former positions of Sung-Sun Cho
Companies | Position | End |
---|---|---|
ProCell Therapeutics, Inc.
![]() ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
Private companies | 1 |
---|---|
ProCell Therapeutics, Inc.
![]() ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Sung-Sun Cho